Advancements in Allergy and Asthma Care, Ltd. – Trademark Portfolio

Entity Type: 03

Advancements in Allergy and Asthma Care, Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include FARM PROGRAM. The owner is based in Minnetonka, MN.

12450 Wayzata Boulevard, Suite 215

Minnetonka, MN 55305

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Advancements in Allergy and Asthma Care, Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Advancements in Allergy and Asthma Care, Ltd. have?

Advancements in Allergy and Asthma Care, Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Advancements in Allergy and Asthma Care, Ltd. file in?

Advancements in Allergy and Asthma Care, Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 44 (Medical Services). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are Advancements in Allergy and Asthma Care, Ltd.'s most well-known trademarks?

Advancements in Allergy and Asthma Care, Ltd.'s registered trademark portfolio includes well-known marks such as FARM PROGRAM. These are among 1 currently registered trademark in the portfolio.

What is Advancements in Allergy and Asthma Care, Ltd.'s trademark registration success rate?

Advancements in Allergy and Asthma Care, Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.